STATE STREET CORP - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 53 filers reported holding SPERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$157,918
-1.6%
130,511
+17.9%
0.00%
Q2 2023$160,5310.0%110,7110.0%0.00%
Q1 2023$160,531
-58.1%
110,711
-50.0%
0.00%
Q4 2022$383,060
+109.3%
221,422
+142.5%
0.00%
Q3 2022$183,000
+147.3%
91,311
-9.0%
0.00%
Q2 2022$74,000
-98.3%
100,384
-79.8%
0.00%
Q1 2022$4,326,000
-68.0%
497,185
-41.1%
0.00%
-100.0%
Q4 2021$13,512,000
-8.6%
843,955
+5.1%
0.00%0.0%
Q3 2021$14,778,000
+30.6%
802,691
-1.0%
0.00%0.0%
Q2 2021$11,318,000
-43.3%
810,738
-40.2%
0.00%0.0%
Q1 2021$19,968,000
+203.9%
1,356,543
+300.4%
0.00%
Q4 2020$6,570,000
+106.1%
338,831
+18.6%
0.00%
Q3 2020$3,187,000
-18.4%
285,592
-1.0%
0.00%
Q2 2020$3,904,000
+73.5%
288,574
+3.6%
0.00%
Q1 2020$2,250,000
+12.2%
278,443
+33.5%
0.00%
Q4 2019$2,006,000
-4.1%
208,591
+5.8%
0.00%
Q3 2019$2,091,000
+7.2%
197,226
+16.3%
0.00%
Q2 2019$1,951,000
+39.6%
169,531
+55.3%
0.00%
Q1 2019$1,398,000
+49.5%
109,135
-28.2%
0.00%
Q4 2018$935,000
-30.4%
152,093
+18.9%
0.00%
Q3 2018$1,344,000
+49.7%
127,925
+109.0%
0.00%
Q2 2018$898,000
+99.1%
61,198
+93.2%
0.00%
Q1 2018$451,00031,6730.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$17,639,00016.57%
Aquilo Capital Management, LLC 1,054,356$13,506,0005.98%
VHCP Management II, LLC 474,015$6,072,0001.78%
AWM Investment Company, Inc. 562,296$7,203,0001.42%
Alphabet Inc. 1,112,473$14,251,0000.74%
BVF INC/IL 460,706$5,902,0000.66%
DAFNA Capital Management LLC 70,000$897,0000.39%
Artal Group S.A. 600,000$7,686,0000.31%
Rock Springs Capital Management LP 525,000$6,725,0000.26%
Orbimed Advisors 507,471$6,501,0000.10%
View complete list of SPERO THERAPEUTICS INC shareholders